5th Crick International Cancer Conference

5-7 October 2025 | London UK

EXHIBITOR

We’re proud to be an exhibition sponsor at the 5th Crick International Cancer Conference, on 5–7 October 2025 at the Francis Crick Institute in London. Gathering leading cancer biologists, clinicians and translational researchers, this event event discusses themes such as tumour metabolism, immune-cancer interactions, cellular state regulation, metastasis, therapy resistance.

Alamar’s core expertise in fluid biomarker analysis speaks directly to the conference’s translational agenda including liquid biopsy assays, proteomic and metabolomic markers, and dynamic biomarker tracking across therapy time-courses. We look forward to engaging with researchers pushing the frontiers of oncology, demonstrating how our technologies can accelerate biomarker discovery, validation, and ultimately translation into improving patient outcomes.

Visit Conference Site
Linkedin

Steve Williams, MD, PhD

CSO

Dr. Willams serves as the company’s Chief Scientific Officer. He was previously Chief Medical Officer at Standard Biotools and at SomaLogic where he pioneered the discipline for discovery and validation of predictive, diagnostic and prognostic models using machine-learning applied to large-plex proteomics. 20 such tests were used for drug characterization, safety and efficacy when incorporated in clinical drug trials at Pharma/Biotech and 17 different multivariate tests were validated and translated into regulated healthcare uses. Prior to SomaLogic, Dr. Williams was at Pfizer in the UK and the USA as a clinical triallist in Translational Medicine, and subsequently as VP, Global Clinical Technology. He sat on the National Advisory Council for the National Institute of Biomedical Imaging and Bioengineering, the Executive Committee for the FNIH Biomarkers Consortium, and worked with FDA and PhRMA on developing evidentiary standards for biomarker qualification. Dr. William’s medical training was in London, at Charing Cross and Westminster Medical School, followed by a PhD in medicine/physiology at the same institution and training in Radiology at the University of Newcastle Upon Tyne. Steve is co-inventor on 26 proteomics patents and author/coauthor on multiple foundational proteomics manuscripts.

Linkedin

Justin McAnear

CFO

Mr. McAnear serves as the company’s Chief Financial Officer. He brings over 25 years of operational and financial leadership experience across various sectors and was instrumental in taking 10x Genomics public in 2019, serving as its CFO for over five years. Mr. McAnear served for over 3 years as Tesla’s VP of Worldwide Finance and Operations, supporting landmark initiatives such as the Model X and Model 3 launches and Solar City acquisition.  He also held various roles at Apple and J&J earlier in his career and served as a naval officer and aviator for over 9 years.